Projects

Projects per year 1970 2024

• 24 Active
• 35 Finished

Projects per year

Search results

• Active

  FWOAL1019: High intensity focused ultrasound and mRNA nanomedicines: a new strategy to induce and boost anti-tumor immunity

  Breckpot, K.

  1/01/21 → 31/12/24

  Project: Fundamental

• IOFPOC42: IOF PoC “MOTIF: MOdification of T cells In situ for altered Functionality”

  Devoogdt, N., Breckpot, K., Meeus, F., De Groof, T. & De Vlaeminck, Y.

  1/01/21 → 31/12/22

  Project: Applied

• ani257: CARGO: advancing chimeric antigen receptor T cell therapy using nanobody-displaying lentiviral vectors

  Breckpot, K.

  1/11/20 → 31/10/21

  Project: Fundamental

• FWOSB101: CARGO: advancing chimeric antigen receptor T cell therapy using nanobody-displaying lentiviral vectors.

  Meeus, F. & Breckpot, K.

  1/11/20 → 31/10/22

  Project: Fundamental

• BRGRD44: Joint R&D 2020: "IMPACT: Invigorating precision Medicine by Predictive imaging of sdAb-based anti-Cancer Theranostics"

  Keyaerts, M., Krasniqi, A., Breckpot, K. & Goyvaerts, C.

  1/07/20 → 30/06/23

  Project: Applied

• OZR3588: Financiering FWO hercules: ERA platform: Extended RNA Analysis platform - version 2.0

  Rooman, I., Bouwens, L., Heimberg, H., Neyns, B., Vranken, W., Vanhaecke, T., Massie, A., van Grunsven, L., De Bruyne, E., De Bundel, D., Forsyth, R., Breckpot, K., Van Dooren, S., De Kock, J., Njemini, R. & Laoui, D.

  1/05/20 → 30/04/24

  Project: Fundamental

• IOF3009: GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)

  Lahoutte, T., Devoogdt, N., Keyaerts, M., Van Ginderachter, J., Laoui, D., Raes, G., Breckpot, K. & Goyvaerts, C.

  1/01/20 → 31/12/24

  Project: Applied

• FWOSB80: Combining targeted radionuclide therapy and cancer immunotherapy to advance precision medicine through innovation.

  Breckpot, K., Devoogdt, N., D'Huyvetter, M., Keyaerts, M. & Ertveldt, T.

  1/11/19 → 31/10/21

  Project: Fundamental

• FWOSB81: Eccentric: Enhancing the function of Cancer Countering Effector cells using Nanobodies Targeting Regulatory Immune Checkpoints

  Breckpot, K., Devoogdt, N., Keyaerts, M. & Awad, R. M.

  1/11/19 → 31/10/21

  Project: Fundamental

• OZR3458: Research Council - Backup mandate Cleo Goyvaerts - Creation of a 3D CRiMe scene to unravel Cytotoxicity Resistant Mechanisms in non-small cell lung cancer.

  Goyvaerts, C. & Breckpot, K.

  1/10/19 → 30/09/21

  Project: Fundamental

• VLAHLT1: ICON project PERSOMED

  Breckpot, K. & Thielemans, K.

  1/10/19 → 30/09/22

  Project: Applied

• FWOAL934: Smart design nanoParticles to Activate immune Responses against Cancer (SPARC)

  Breckpot, K., Keyaerts, M., Barbé, K. & De Smedt, S.

  1/01/19 → 31/12/22

  Project: Fundamental

• FWOSB59: Enhancing the immunogenicity and antitumor efficacy of virotherapy by supplementing an oncolytic virus with checkpoint inhibition and immunological cell death inducers

  Kalus, P., Aerts, J. & Breckpot, K.

  1/01/19 → 31/12/22

  Project: Fundamental

• ANI215: TrimixDC-NEO

  Thielemans, K. & Breckpot, K.

  1/01/19 → 31/12/22

  Project: Fundamental

• FWOSB58: Development of a NanoCAR-T cell approach for the treatment of multiple myeloma

  Hanssens, H., Devoogdt, N., De Veirman, K. & Breckpot, K.

  1/01/19 → 31/12/22

  Project: Fundamental

• ANI216: Prioritization of neoantigens by the combination of in silico search and mass spectrometry.

  Thielemans, K. & Breckpot, K.

  1/01/19 → 31/12/22

  Project: Fundamental

• FWOTM900: Modulating epigenetic mechanisms to enhance cancer immunotherapy.

  Breckpot, K., De Beck, L. & Maes, K.

  1/10/18 → 30/09/22

  Project: Fundamental

• HERC43: FWO Hercules MZW: Platform for cell analysis after radioactivity based Molecular Imaging and targeted Therapy of cancer (PeRMIT)

  Keyaerts, M., Breckpot, K., De Veirman, K. & Van Ginderachter, J.

  1/05/18 → 30/04/23

  Project: Fundamental

• IWTOO25: Baekeland mandate: In situ mRNA vaccination: bringing the fight to the tumor

  Breckpot, K., Thielemans, K. & Locy, H.

  1/01/18 → 30/04/22

  Project: Applied

• FWOSBO21: SBO: MATATUM : Validation and druggability development of macrophage-specific targets in the tumor microenvironment

  Van Ginderachter, J., Breckpot, K., Lahoutte, T., Devoogdt, N. & Raes, G.

  1/01/18 → 31/12/21

  Project: Applied

• FWOSB43: Nanobody-mediated imaging and blocking of the inhibitory receptor LAG-3

  Lecocq, Q., Breckpot, K., Devoogdt, N. & Keyaerts, M.

  1/01/18 → 31/12/21

  Project: Fundamental

• SRP48: Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)

  Thielemans, K., Vanderkerken, K. & Breckpot, K.

  1/11/17 → 31/10/22

  Project: Fundamental

• ANI184: Nanobody-targeted radionuclide therapy and immune therapy: a perfect match in the area of combination therapy.

  Breckpot, K. & Keyaerts, M.

  1/01/17 → 31/12/21

  Project: Fundamental

• OZR2835: Onderzoeksgroep Alliantie VUB - UGent - Research Consortium on particle based immunotherapy

  Breckpot, K. & De Smedt, S.

  10/07/15 → …

  Project: Policy Based